Didier Leroy

7.6k total citations · 2 hit papers
73 papers, 3.7k citations indexed

About

Didier Leroy is a scholar working on Public Health, Environmental and Occupational Health, Molecular Biology and Computational Theory and Mathematics. According to data from OpenAlex, Didier Leroy has authored 73 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Public Health, Environmental and Occupational Health, 19 papers in Molecular Biology and 19 papers in Computational Theory and Mathematics. Recurrent topics in Didier Leroy's work include Malaria Research and Control (52 papers), Mosquito-borne diseases and control (37 papers) and Computational Drug Discovery Methods (19 papers). Didier Leroy is often cited by papers focused on Malaria Research and Control (52 papers), Mosquito-borne diseases and control (37 papers) and Computational Drug Discovery Methods (19 papers). Didier Leroy collaborates with scholars based in Switzerland, France and United Kingdom. Didier Leroy's co-authors include Benjamin Blasco, David A. Fidock, E.M. Chambaz, Robert E. Sinden, Jean-Karim Hèriché, Michael J. Delves, Yves Goldberg, Thierry Rabilloud, Franck Lebrin and Jeremy N. Burrows and has published in prestigious journals such as Science, Journal of Biological Chemistry and Nature Medicine.

In The Last Decade

Didier Leroy

72 papers receiving 3.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Blockade of PI3Kγ suppresses joint inflammation and damage in mouse models of rheumatoid arthritis

2005 650 citations Didier Leroy et al. Nature Medicine profile →
Antimalarial drug resistance: linking Plasmodium falciparum parasite biology to the clinic

2017 344 citations Benjamin Blasco, Didier Leroy et al. Nature Medicine profile →

Peers

Countries citing papers authored by Didier Leroy

Since Specialization

Citations

This map shows the geographic impact of Didier Leroy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Didier Leroy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Didier Leroy more than expected).

Fields of papers citing papers by Didier Leroy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Didier Leroy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Didier Leroy. The network helps show where Didier Leroy may publish in the future.

Co-authorship network of co-authors of Didier Leroy

This figure shows the co-authorship network connecting the top 25 collaborators of Didier Leroy. A scholar is included among the top collaborators of Didier Leroy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Didier Leroy. Didier Leroy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	An all-in-one pipeline for the in vitro discovery and in vivo testing of Plasmodium falciparum malaria transmission blocking drugs 2025 ·Nature Communications ·Nicolas M. B. Brancucci, (unknown), Geert‐Jan van Gemert, Yu Xiao, (unknown), (unknown), (unknown), Marc Chambon, Gerardo Turcatti, Ludovic Halby, Benjamin Blasco, Maëlle Duffey, Paola B. Arimondo, Teun Bousema, Artur Scherf, Didier Leroy, Taco W. A. Kooij, Matthias Rottmann, Till S. Voss	1
2	Anopheles mosquito survival and pharmacokinetic modeling show the mosquitocidal activity of nitisinone 2025 ·Science Translational Medicine ·Lee R. Haines, Anna Trett, Clair Rose, Natalia García, Marcos Sterkel, Dagmara McGuinness, Clément Regnault, Michael P. Barrett, Didier Leroy, Jeremy N. Burrows, Giancarlo A. Biagini, L. Ranganath, Ghaith Aljayyoussi, Álvaro Acosta-Serrano	3
3	Defining the next generation of severe malaria treatment: a target product profile 2024 ·Malaria Journal ·Jane Achan, Aïssata Barry, Didier Leroy, (unknown), Stephan Duparc, Wiweka Kaszubska, Preetam Gandhi, (unknown), (unknown), Bernhards Ogutu, Terrie E. Taylor, Sanjeev Krishna, (unknown), (unknown), (unknown)	5
4	Eliminating malaria transmission requires targeting immature and mature gametocytes through lipoidal uptake of antimalarials 2024 ·Nature Communications ·(unknown), (unknown), Janette Reader, Mariëtte van der Watt, Jandeli Niemand, D. Albert Joubert, Giulia Siciliano, Pietro Alano, Mathew Njoroge, Kelly Chibale, Esperanza Herreros, Didier Leroy, Lyn‐Marié Birkholtz	2
5	Genetic complexity alters drug susceptibility of asexual and gametocyte stages of Plasmodium falciparum to antimalarial candidates 2024 ·Antimicrobial Agents and Chemotherapy ·(unknown), Mariëtte van der Watt, (unknown), (unknown), Bryan Greenhouse, Didier Leroy, Jandeli Niemand, Lyn‐Marié Birkholtz	1
6	Transmission-blocking drugs for malaria elimination 2022 ·Trends in Parasitology ·Lyn‐Marié Birkholtz, Pietro Alano, Didier Leroy	42
7	Assessing risks of Plasmodium falciparum resistance to select next-generation antimalarials 2021 ·Trends in Parasitology ·Maëlle Duffey, Benjamin Blasco, Jeremy N. Burrows, Timothy N. C. Wells, David A. Fidock, Didier Leroy	52
8	Host-directed therapy, an untapped opportunity for antimalarial intervention 2021 ·Cell Reports Medicine ·Ling Wei, (unknown), Didier Leroy, David H. Drewry, Danny W. Wilson, Alexis Kaushansky, Christian Doerig	30
9	Detection of Flares by Decrease in Physical Activity, Collected Using Wearable Activity Trackers in Rheumatoid Arthritis or Axial Spondyloarthritis: An Application of Machine Learning Analyses in Rheumatology 2018 ·Arthritis Care & Research ·Laure Gossec, Frédéric Guyard, Didier Leroy, (unknown), (unknown), (unknown), Anna Moltó, Jérémie Sellam, Violaine Foltz, Frédérique Gandjbakhch, Christophe Hudry, Stéphane Mitrovic, Bruno Fautrel, H. Servy	94
10	Screening a protein kinase inhibitor library against Plasmodium falciparum 2017 ·Malaria Journal ·Irene Hallyburton, Raffaella Grimaldi, Andrew Woodland, Beatriz Baragaña, Torsten Luksch, Daniel Spinks, (unknown), Didier Leroy, David Waterson, Alan H. Fairlamb, Paul G. Wyatt, Ian H. Gilbert, Julie A. Frearson	16
11	Modelling mosquito infection at natural parasite densities identifies drugs targeting EF2, PI4K or ATP4 as key candidates for interrupting malaria transmission 2017 ·Scientific Reports ·Koen J. Dechering, Hans-Peter Duerr, Karin M. J. Koolen, Geert‐Jan van Gemert, Teun Bousema, Jeremy N. Burrows, Didier Leroy, Robert W. Sauerwein	18
12	Antimalarial drug resistance: linking Plasmodium falciparum parasite biology to the clinic breakdown → 2017 ·Nature Medicine ·Benjamin Blasco, Didier Leroy, David A. Fidock	344
13	Nowhere to hide: interrogating different metabolic parameters of Plasmodium falciparum gametocytes in a transmission blocking drug discovery pipeline towards malaria elimination 2015 ·Malaria Journal ·Janette Reader, Mariëtte Botha, Anjo Theron, Sonja B. Lauterbach, (unknown), (unknown), (unknown), (unknown), Didier Leroy, Dalu Mancama, Thérèsa L. Coetzer, Lyn‐Marié Birkholtz	69
14	High-Throughput Assay and Discovery of Small Molecules that Interrupt Malaria Transmission 2015 ·Cell Host & Microbe ·David Plouffe, Melanie Wree, Alan Y. Du, Stephan Meister, Fengwu Li, Kailash P. Patra, (unknown), Shinji L. Okitsu, Erika L. Flannery, Nobutaka Kato, Olga Tanaseichuk, Eamon Comer, Bin Zhou, Kelli Kuhen, Yingyao Zhou, Didier Leroy, Stuart L. Schreiber, Christina Scherer, Joseph M. Vinetz, Elizabeth A. Winzeler	110
15	A Male and Female Gametocyte Functional Viability Assay To Identify Biologically Relevant Malaria Transmission-Blocking Drugs 2014 ·Antimicrobial Agents and Chemotherapy ·Andrea Ruecker, Derrick Mathias, Ursula Straschil, Thomas S. Churcher, Rhoel R. Dinglasan, Didier Leroy, Robert E. Sinden, Michael J. Delves	87
16	Defining the biology component of the drug discovery strategy for malaria eradication 2014 ·Trends in Parasitology ·Didier Leroy, Brice Campo, Xavier C. Ding, Jeremy N. Burrows, (unknown)	35
17	The biology of sexual development of Plasmodium: the design and implementation of transmission-blocking strategies 2012 ·Malaria Journal ·Robert E. Sinden, Richard Carter, Chris Drakeley, Didier Leroy	55
18	Anti-malarial drugs: how effective are they against Plasmodium falciparum gametocytes? 2012 ·Malaria Journal ·Christopher L. Peatey, Didier Leroy, Donald L. Gardiner, Katharine R. Trenholme	68
19	Activity of Clinically Relevant Antimalarial Drugs on Plasmodium falciparum Mature Gametocytes in an ATP Bioluminescence “Transmission Blocking” Assay 2012 ·PLoS ONE ·Joël Lelièvre, María Jesús Almela, Sonia Lozano, (unknown), Virginia Franco, Didier Leroy, Esperanza Herreros	186
20	Lte1, Cdc14 and MEN‐controlled Cdk inactivation in yeast coordinate rDNA decompaction with late telophase progression 2009 ·The EMBO Journal ·Elisa Varela, Kenji Shimada, Thierry Laroche, Didier Leroy, Susan M. Gasser	18

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact